Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2017-03-07 to 2017-06-13
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Cross-reference
Reason / purpose for cross-reference:
reference to same study
Reference
Endpoint:
screening for reproductive / developmental toxicity
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2017-03-07 to 2017-06-13
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Reason / purpose for cross-reference:
reference to same study
Qualifier:
according to guideline
Guideline:
OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
Version / remarks:
29 July 2016
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: EPA Health Effects Test Guidelines: OPPTS 870.3650 Combined Repeated Dose Toxicity with the Reproduction/Developmental Toxicity Screening Test
Version / remarks:
July 2000
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Limit test:
no
Species:
rat
Strain:
Wistar
Remarks:
Hsd.Han
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Toxi-Coop Zrt., 1103 Budapest, Cserkesz u. 90
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 11-12 weeks (both sexes)
- Weight at study initiation: males: 327-381 g
females: 202-244 g
- Fasting period before study: no
- Housing: before mating: 2 animals of the same sex/cage; mating: 1 male and 1 female/cage; pregnant females: individually; males after mating: 2/cage;
Type III polypropylene/polycarbonate
- Diet: ad libitum, ssniff SM R/M-Z+H complete diet
- Water: ad libitum, tap water
- Acclimation period: 19 days

DETAILS OF FOOD AND WATER QUALITY: The food is considered not to contain any contaminants that could reasonably be expected to affect the purpose or integrity of the study. The supplier provided an analytical certificate of the standard diet for the batch used. Water quality control analysis and microbiological assessment are performed once in every six months by Government Office of Capital Budapest Department of Public Health and Medical Officer Service.

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/- 3
- Humidity (%): 30-70
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12
Route of administration:
oral: gavage
Vehicle:
water
Remarks:
distilled
Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test item was solved in distilled water in concentrations of 20, 60 and 200 mg/mL. Dosing solutions were prepared not longer than for four days before the administration and stored at room temperature until use.

- VEHICLE
- Concentration in vehicle: 20, 60 and 200 mg/mL
- Amount of vehicle: 5 mL/kg body weight
- Batch no. of Aqua purificata (distilled water): 1702-5502, 1702-5510, 1703-5503 (supplier: Parma Produkt Kft., Budapest, Hungary)

Details on mating procedure:
- M/F ratio per cage: 1/1
- Length of cohabitation: until copulation or 14 days
- Proof of pregnancy: vaginal plug / sperm in vaginal smear referred to as day 0 of pregnancy
- After 14 days of unsuccessful pairing replacement of first male by another male with proven fertility.
- Further matings after two unsuccessful attempts: no
- After successful mating each pregnant female was caged (how): individually
- Any other deviations from standard protocol: none
Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
Analytical control of dosing formulations was performed by LC/MS/MS in the analytical laboratory of test facility twice during the study. Recoveries of the test item in the dosing formulations ranged from 100 - 105 % of the nominal concentrations. Stability and homogeneity in distilled water over the range of relevant concentration has been demostrated at room temperature for at least four days (recoveries from 98 % to 105 %), i.e. the maximum period of solutions administered.
Duration of treatment / exposure:
females: 56-66 days (depending on mating effectiveness)
males: 56-57 days (depending on mating effectiveness)
Frequency of treatment:
daily
Dose / conc.:
100 mg/kg bw/day (actual dose received)
Dose / conc.:
300 mg/kg bw/day (actual dose received)
Dose / conc.:
1 000 mg/kg bw/day (actual dose received)
No. of animals per sex per dose:
12 male and 12 female per dose and control
Control animals:
yes, concurrent vehicle
Details on study design:
- Dose selection rationale: based on results from a 14-day dose-range finding experiment that used the same concentrations
- Rationale for animal assignment: random
Positive control:
none
Parental animals: Observations and examinations:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily

DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: weekly

BODY WEIGHT: Yes
- Time schedule for examinations: weekly (starting on Day 0)

FOOD CONSUMPTION AND COMPOUND INTAKE: Yes
Food consumption was determined weekly by reweighing the given and non-consumed diet with a precision of 1 g during the treatment period except mating phase (pre-mating days 0, 7, 13, gestation days 0, 7, 14 and 21, lactation days 0, 4 and 13). Food consumption of male animals was also determined by weekly interval during post-mating period.

WATER CONSUMPTION AND COMPOUND INTAKE: No



Oestrous cyclicity (parental animals):
The estrous cycle was monitored by examining vaginal smears each day before treatment start for each rat being considered for the study for two weeks. The estrous cycle was evaluated and considered for randomisation. However, some animal not showing typical 4-5 day cycles were included in the study due to the large amount of rats with irregular cycles. Vaginal smears were prepared and estrous cycle was monitored daily from the beginning of the treatment period (2 weeks pre-mating period) and during the mating period until evidence of mating. Vaginal smears were also prepared on the day of necropsy. Smears were stained (1 % aqueous methylene blue solution) and examined microscopically.
Sperm parameters (parental animals):
Parameters examined in P male parental generations:
- testis weight
- epididymis (and prostate and seminal vesicles with coagulating glands) weight
- histopathology of stages of spermatogenesis in the male gonads
- histopathology of interstitial testicular cell structure

Litter observations:
STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: yes
On post-partum day 4, the size of each litter was adjusted to four pups per sex per litter, if it was feasible. Extra pups were eliminated by a random selection. Partial adjustment of litter size was performed if the number of male and female pups did not allow having four of eachsex per litter (for example, five males and three females).

PARAMETERS EXAMINED
The following parameters were examined in F1 offspring:
- number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, anogenital distance (AGD), presence of nipples/areolae in male pups
- From at least 2 pups per litter, blood samples for T4 analysis were collected at post-natal day 4 and post-natal day 13.

GROSS EXAMINATION OF DEAD PUPS:
yes, for external and internal abnormalities

ASSESSMENT OF DEVELOPMENTAL NEUROTOXICITY: No

ASSESSMENT OF DEVELOPMENTAL IMMUNOTOXICITY: No
Postmortem examinations (parental animals):
SACRIFICE
- Male animals: All surviving animals on day 55
- Maternal animals: All surviving animals 14 days post-partum

GROSS PATHOLOGY: Yes
- adrenal glands
- bone with bone marrow and joint (femur)
- brain (representative regions: cerebrum, cerebellum, pons and medulla oblongata)
- eyes (lachrymal gland with Harderian glands)
- female mammary gland
- gonads (testis with epididymides, ovaries, uterus with fallopian tube and vagina)
- gross lesions
- heart
- kidneys
- large intestines (caecum, colon, rectum, incl. Peyer's patches)
- liver
- lungs (with main stem bronchi)
- lymph nodes (submandibular, mesenteric)
- muscle (quadriceps)
- esophagus
- pancreas
- pituitary
- prostate
- salivary glands (submandibular)
- sciatic nerve
- seminal vesicle with coagulating gland
- skin
- small intestines (representative regions: duodenum, ileum, jejunum)
- spinal cord (at three levels: cervical, mid-thoracic and lumber
- spleen
- sternum
- stomach
- thymus
- thyroid + parathyroid
- trachea
- urinary bladder

HISTOPATHOLOGY : Yes (control and high dose group)
Histopathological examinations were performed on the following preserved organs and tissues of all animals in the control and high dose groups (12 per sex):
- ovaries (Primodial, secondary and teriary follicles; Corpora lutea)
- uterus
- vagina
- testes
- epididymides
- seminal vesicle with coagulating gland
- thymus (one male in low dose group due to hemorrhage)
The tissues indicated above were prepared for microscopic examination and weighed, respectively. In particular, stages of spermatogenesis in the male gonads and histopathology of interstitial testicular cell structure were examined.

Full histopathological examinations were performed on the following preserved organs and tissues of selected animals in the control and high dose groups (5 per sex):
- adrenal glands
- aorta
- bone marrow
- brain
- cecum
- colon
- duodenum
- eyes + optic nerves
- esophagus
- harderian glands
- heart
- ileum
- jejunum
- kidneys
- lachrymal glands
- liver
- lungs
- mesenteric lymph nodes
- muscle (quadriceps)
- pancreas
- pituitary
- prostate
- rectum
- salivary glands (subm.)
- sciatic nerve
- skin
- spinal cord
- spleen
- sternum
- stomach - forestomach
- subm. lymph nodes
- thymus
- thyroid + parathyroid
- trachea
- urinary bladder
From all parent rats, blood samples for T4 analysis were collected at termination (males and females)
Postmortem examinations (offspring):
SACRIFICE
- The F1 offspring were sacrificed latest at 13 days of age.

GROSS NECROPSY: Dead pups and pups euthanized at day 13 post-partum, or shortly thereafter, were carefully examined for gross abnormalities.

HISTOPATHOLOGY / ORGAN WEIGTHS: No
Statistics:
Depending on variance homogeneity between groups (Bartlett's test), parametric or non-parametric (Kruskal-Wallis test) ANOVA was performed, with subsequent inter-group comparisons (Duncan multiple range test or Mann-Whitney U-Test) in case of significant ANOVA results. If applicable, the Chi-square test was performed.
Reproductive indices:
Male reproduction data:
- Male mating index
- Male fertility index

Female reproduction and delivery data:
- Female mating index
- Female fertility index
- Gestation index
Offspring viability indices:
- Post implantation mortality
- Post-natal mortality
- Survival index
- Sex ratio
Clinical signs:
no effects observed
Description (incidence and severity):
Daily clinical observation:
No treatment-related signs of systemic toxicity were detected at any dose level at the daily clinical observations (100, 300 and 1000 mg/kg bw/day, male or female).

Detailed weekly clinical observation:
The behavior and physical condition of animals was not affected by the test item at any dose level (100, 300 or 1000 mg/kg bw/day) based on the weekly detailed clinical observations during the entire treatment period.
Mortality:
no mortality observed
Description (incidence):
There was no mortality in any group during the course of study.
Body weight and weight changes:
no effects observed
Description (incidence and severity):
No test item related effects were noted on the mean body weight and body weight gain values at 100, 300 or 1000 mg/kg bw/day. There were no significant differences between the control and test item treated groups in the body weight or body weight gain at any occasion.
Food consumption and compound intake (if feeding study):
no effects observed
Description (incidence and severity):
There were no test item related differences in the mean daily food consumption in any test item treated group when compared to the control during the study. There were no significant differences between the control and test item treated groups in the mean daily food consumption at any occasion.
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
no effects observed
Description (incidence and severity):
There were no pathological changes in the examined hematological and blood coagulation parameters in any of the groups (male and female, 100, 300 or 1000 mg/kg bw/day). The examined hematological and blood coagulation parameters were comparable in male and female animals of control and all test item treated groups and statistical significance was not observed.
Clinical biochemistry findings:
effects observed, non-treatment-related
Description (incidence and severity):
There were no test item related adverse effects on the examined clinical chemistry parameters at 100, 300 or 1000 mg/kg bw/day (male or female).
These sporadic statistical differences are considered to be of no toxicological relevance because the differences between the control and test item treated
groups were of minor degree, the values were within the historical controls and/or they were not related to doses.
Urinalysis findings:
not examined
Behaviour (functional findings):
no effects observed
Description (incidence and severity):
Functional observations did not demonstrate any test item related changes. The behavior, physical condition and reactions to different type of stimuli of animals selected for examination are considered to be normal in all groups (100, 300 and 1000 mg/kg bw/day, control).
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
effects observed, non-treatment-related
Histopathological findings: non-neoplastic:
no effects observed
Description (incidence and severity):
Histopathological examinations did not reveal any test item related alterations in the organs or tissues of male or female animals at 1000 mg/kg bw/day. No test item related alterations in organs and tissues and no morphological evidence of acute or subacute injury to the various organs were observed. There was no morphological evidence of acute or subacute injury (degeneration, inflammation, necrosis, etc.) of the stomach, the small and large intestines, the liver, the pancreas, the cardiovascular system, the urinary system, the immune system, the hematopoietic system, the skeleton, the muscular system, the male and female reproductive system or the central or peripheral nervous system in the animals.The cytomorphology of the endocrine glands were the same in the control and the treated animals.
Histopathological findings: neoplastic:
not examined
Other effects:
no effects observed
Reproductive function: oestrous cycle:
effects observed, non-treatment-related
Description (incidence and severity):
A test item influence on the estrous cycle was not detected at any dose level (100, 300 or 1000 mg/kg bw/day). There were no significant differences between the control and treated groups in the number or percentage of animals with regular cycles, in the mean number of cycles, mean length of cycles, mean number of days in estrous or diestrous during the pre-mating period.
The mean number of days in pro-estrous was statistically significantly higher in the 300 mg/kg bw/day group compared to their control. As all females in this group had normal and regular estrous cycle during the pre-mating period and no dose-dependent differences were observed, this slight difference is considered to be unrelated to the test item.
Reproductive function: sperm measures:
no effects observed
Description (incidence and severity):
In all male animals, the investigated organs of reproductive system (testes, epididymides,prostate and seminal vesicles with coagulating gland) were histologically normal and characteristic on the sexually mature organism in all cases. The various spermatogenic cells (spermatogonia, spermatocytes, spermatids and spermatozoa), representing different phases in the development and differentiation of the spermatozoons and the interstitial cells were the same in quantity and morphologically in the testes of investigated control and treated animals. The histological picture of epididymides, seminal vesicles, and coagulating glands was normal in all animals as well.
Reproductive performance:
effects observed, non-treatment-related
Description (incidence and severity):
The examined parameters of reproductive performance were not affected by the test item at 100, 300 or 1000 mg/kg bw/day (male and female). There was statistically significant difference between the control and test item treated groups of male animals at 100, 300 and 1000 mg/kg bw/day in copulatory indices as one pair of control failed to mate during the 14-day period resulting in lower copulatory index. Thus, these statistically significant differences with respect to the control are considered to be indicative of biological variation and not related to the test item. Statistically significantly lower fertility index was observed in the male 1000 mg/kg bw/day group when compared to the control because one male animal in this group mated however the female was not pregnant. The lower fertility index of this group met the historical controls; therefore, it is considered to be not related to the test item.
The number of pregnant females and dams delivered, the mean number of implantations, post-implantation loss, duration of pregnancy, and pups births (total, live, still birth, viable) and live birth index were comparable in all groups. In the control group the number of viable pups on post-natal day 0 (PN0) was relatively low: 89 % of the liveborns in this group were viable on PN0. In the test item treated groups this value was between 96 % and 99 %. This observation in the control group is considered as normal biological variability.
Key result
Dose descriptor:
NOAEL
Effect level:
1 000 mg/kg bw/day (actual dose received)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: No test substance related adverse effects were observed up to the highest dose tested.
Key result
Critical effects observed:
no
Clinical signs:
no effects observed
Description (incidence and severity):
Test item related clinical signs were not detected in the offspring between postnatal days 0 and 13.
Mortality / viability:
mortality observed, non-treatment-related
Description (incidence and severity):
There was no test item related effect on offspring’s extra uterine mortality.
The highest mean number of dead offspring per litter between post-natal days 0 and 13 was observed in the control and the 300 mg/kg bw/day groups (1.3 dead pups per litter) while in the 100 and 1000 mg/kg bw/day groups it was only 0.2 per litter. The survival indices are in good correlation with the mean number of dead pups. These differences did not attain statistical significance and there is no dose dependence observed and, therefore, they are considered to have no toxicological relevance.
Body weight and weight changes:
effects observed, non-treatment-related
Description (incidence and severity):
A test item related effect on the body weight development of the offspring was not found.
The mean litter weights as well as the mean litter weight gain were similar in the control and in all test item treated groups (100, 300 and 1000 mg/kg bw/day) on postnatal days 0, 4 and 13.
Slight changes with statistical significance were detected in the mean pup weights and mean pup weight gain; however, these minor differences without a relation to dose are considered to have no toxicological relevance.
Food consumption and compound intake (if feeding study):
not examined
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Sexual maturation:
not examined
Anogenital distance (AGD):
effects observed, non-treatment-related
Description (incidence and severity):
The anogenital distances (AGD; absolute and normalized) were not affected by the test item at 100, 300 and 1000 mg/kg bw/day.
Statistical significances were observed for decreased or increased anogenital distances (absolute and/or normalized) in male or female pups of all dose groups. These changes were minor and are considered to be indicative of biological variations and not related to the test item.
Nipple retention in male pups:
no effects observed
Description (incidence and severity):
Nipples/areoles were not visible in any of the examined male offspring in the control or 100, 300 or 1000 mg/kg bw/day groups on postnatal day 13.
Organ weight findings including organ / body weight ratios:
not examined
Gross pathological findings:
no effects observed
Description (incidence and severity):
Test item related macroscopic alterations were not found in offspring subjected to gross pathological examination. There were no macroscopic changes in the organs or tissues of stillborn or dead offsprings.
Histopathological findings:
not examined
Other effects:
no effects observed
Description (incidence and severity):
There were no test item related differences between the control and test item treated groups in the ratio or in the litter means of genders on postnatal days 0, 4 or 13. There were no significant differences with respect to the control in the T4 thyroid hormone levels in offspring sampled on postnatal day 13 at any dose levels.
Behaviour (functional findings):
not examined
Developmental immunotoxicity:
not examined
Key result
Dose descriptor:
NOAEL
Generation:
F1
Effect level:
1 000 mg/kg bw/day (actual dose received)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: No test substance related adverse effects were observed up to the highest dose tested.
Key result
Critical effects observed:
no
Key result
Reproductive effects observed:
no
Conclusions:
Under the conditions of the present study, the test item did not cause signs of systemic toxicity in parental male and female Hsd.Han: Wistar rats at 100, 300 or 1000 mg/kg bw/day doses administered by oral gavage. Based on these observations the NOAEL for systemic toxicity of male/female rats was determined to be 1000 mg/kg bw/day. The NOAEL for reproductive performance of male/female rats and for F1 Offspring was 1000 mg/kg bw/day, respectively.
Executive summary:

A study according OECD TG 422 was performed to investigate possible effects of the test item on reproduction and development when repeatedly administered orally to rats compared to control animals. Four groups of Wistar rats consisting of 12 animals per group and sex were administered by gavage once daily doses of 0 (vehicle only), 100, 300 and 1000 mg/kg bw/day. The suitability of distilled water as vehicle for the test item was analytically verified up front as the test item was stable in distilled water at room temperature for at least four days. The concentration of the substance in the dosing formulations administered to the animals was confirmed twice during the study. All animals of the parent (P) generation were dosed prior to mating (14 days) and throughout mating. In addition, males received the test item or vehicle after mating up to the day before necropsy (altogether 56 or 57 days). Females were additionally exposed through the gestation period and up to lactation days 12-20, i.e. up to the day before necropsy (altogether for 56 to 66 days). Observations included mortality, clinical signs, body weight, food consumption, mating, pregnancy and delivery process, as well as development of offspring. Estrous cycle was monitored by examining vaginal smears before the treatment for two weeks and for two weeks from the beginning of the treatment period (two weeks pre-mating period) and during the mating period until evidence of mating. The dams were allowed to litter and rear their offspring up to day 13 post-partum. Litters were weighed and offspring were observed for possible abnormalities and were euthanized on post-natal day 13 or shortly thereafter. Blood samples were collected for determination of serum levels of thyroid hormones (T4) from 2-8 pups per litter on post-natal day 4, from all dams and from 4-7 pups per litter at termination on post-partum/post-natal day 13 and from all parent male animals at termination. All parental animals were subjected to gross pathology one day after the last treatment. The body weight, brain weight, weight of the testes, epididymides and prostate and seminal vesicles with coagulating glands as a whole of all adult male animals were determined. Histopathology examination was performed on ovaries, uterus, vagina, testes, epididymides, prostate and seminal vesicles with coagulating gland in the control and high dose groups (male or female). Five dams and the male mating partners were randomly selected from each group to examine further signs of toxicity such as functional observations, hematology, blood coagulation, clinical chemistry, gross necropsy, and organ weighing as well as full histopathology in the control and high dose groups.

There was no mortality in any group during the course of study. Clinical signs of systemic toxicity related to the test item were not detected at any dose level, neither at the daily nor at the detailed weekly clinical observations. At the same intervals, the behavior and physical condition of the animals was not impaired at each dose level (100, 300 or 1000 mg/kg bw/day) during the entire treatment period. Test item related changes of the body weight or body weight gain were not detected. The body weight development was not disturbed and comparable in the control and test item treated groups. The mean daily food consumption was not affected by the test item in male or female animals at all test item groups during the entire study (pre-mating, post-mating, gestation and lactation periods). There were no test item related differences between the control and test item treated groups in the examined parameters of reproductive performance, and in the delivery parameters of dams (100, 300 and 1000 mg/kg bw/day). Clinical pathology examinations (hematology, blood coagulation, clinical chemistry and thyroid hormone levels) did not reveal toxicological relevant alterations related to the test item. Specific macroscopic alterations related to the test item were not found at necropsy. There were no test item related changes in the weights (absolute and relative to body or brain weights) of selected organs in the animals at any dose level.

Histopathological examinations of the selected organs (ovaries, uterus, vagina, testes, epididymides, prostate and seminal vesicles with coagulating gland) did not reveal any test item related changes at the highest dose of 1000 mg/kg bw/day. During full histopathology, there were no changes related to the test item in organs or tissues of selected animals (male or female) at 1000 mg/kg bw/day. No adverse findings on the offspring’s development were detected (mortality, clinical signs and body weight, anogenital distance and nipple retention in male pups, necropsy).

Under the conditions of the present study, the substance did not cause signs of systemic toxicity in parental male and female Hsd.Han: Wistar rats at 100, 300 or 1000 mg/kg bw/day doses administered by oral gavage and the test item did not adversely influence the reproductive performance (gonad function, mating behavior, conception, parturition) in parental male and female rats at the doses of 100, 300 or 1000 mg/kg bw/day. The development of the F1 offspring was not impaired at any dose level from birth to post-natal day 13 after repeated oral administration of dams. Based on these observations the NOAEL were determined as follows:

NOAEL for systemic toxicity of male/female rats: 1000 mg/kg bw/day

NOAEL for reproductive performance of male/female rats: 1000 mg/kg bw/day

NOAEL for F1 Offspring: 1000 mg/kg bw/day

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2019
Report date:
2019

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
Version / remarks:
29 July 2016
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: EPA Health Effects Test Guidelines: OPPTS 870.3650 Combined Repeated Dose Toxicity with the Reproduction/Developmental Toxicity Screening Test
Version / remarks:
July 2000
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
2-(4-morpholinyl)ethansulfonic acid hydrate
Cas Number:
1266615-59-1
Molecular formula:
C6H13NO4S * xH2O
IUPAC Name:
2-(4-morpholinyl)ethansulfonic acid hydrate
Test material form:
solid: particulate/powder

Test animals

Species:
rat
Strain:
Wistar
Remarks:
Hsd.Han
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Toxi-Coop Zrt., 1103 Budapest, Cserkesz u. 90
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 11-12 weeks (both sexes)
- Weight at study initiation: males: 327-381 g
females: 202-244 g
- Fasting period before study: no
- Housing: before mating: 2 animals of the same sex/cage; mating: 1 male and 1 female/cage; pregnant females: individually; males after mating: 2/cage;
Type III polypropylene/polycarbonate
- Diet: ad libitum, ssniff SM R/M-Z+H complete diet
- Water: ad libitum, tap water
- Acclimation period: 19 days

DETAILS OF FOOD AND WATER QUALITY: The food is considered not to contain any contaminants that could reasonably be expected to affect the purpose or integrity of the study. The supplier provided an analytical certificate of the standard diet for the batch used. Water quality control analysis and microbiological assessment are performed once in every six months by Government Office of Capital Budapest Department of Public Health and Medical Officer Service.

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/- 3
- Humidity (%): 30-70
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Details on route of administration:
The test item was administered orally by gavage. The route of application was selected in compliance with international guidelines. The oral route is a possible route of human exposure to the test item.
Vehicle:
water
Remarks:
distilled
Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test item was solved in distilled water in concentrations of 20, 60 and 200 mg/mL. Dosing solutions were prepared not longer than for four days before the administration and stored at room temperature until use.

- VEHICLE
- Concentration in vehicle: 20, 60 and 200 mg/mL
- Amount of vehicle: 5 mL/kg body weight
- Batch no. of Aqua purificata (distilled water): 1702-5502, 1702-5510, 1703-5503 (supplier: Parma Produkt Kft., Budapest, Hungary)

Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
Analytical control of dosing formulations was performed by LC/MS/MS in the analytical laboratory of test facility twice during the study. Recoveries of the test item in the dosing formulations ranged from 100 - 105 % of the nominal concentrations. Stability and homogeneity in distilled water over the range of relevant concentration has been demostrated at room temperature for at least four days (recoveries from 98 % to 105 %), i.e. the maximum period of solutions administered.
Duration of treatment / exposure:
females: 56-66 days (depending on mating effectiveness)
males: 56-57 days (depending on mating effectiveness)
Frequency of treatment:
daily
Doses / concentrationsopen allclose all
Dose / conc.:
100 mg/kg bw/day (actual dose received)
Dose / conc.:
300 mg/kg bw/day (actual dose received)
Dose / conc.:
1 000 mg/kg bw/day (actual dose received)
No. of animals per sex per dose:
12 male and 12 female per dose and control
Control animals:
yes, concurrent vehicle
Details on study design:
- Dose selection rationale: based on results from a 14-day dose-range finding experiment that used the same concentrations
- Rationale for animal assignment: random
Positive control:
none

Examinations

Observations and examinations performed and frequency:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily

DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: weekly

BODY WEIGHT: Yes
- Time schedule for examinations: weekly (starting on Day 0)

FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: Yes (body weight gain only)

WATER CONSUMPTION AND COMPOUND INTAKE: No

OPHTHALMOSCOPIC EXAMINATION: No

HAEMATOLOGY: Yes
- Time schedule for collection of blood: approx. 16 hours after last treatment (food deprived)
- Anaesthetic used for blood collection: Yes (isofluran)
- Animals fasted: Yes (approx. 16 hours)
- How many animals: 5 males and 5 females per group (randomly selected)
- Parameters examined:
- white blood cell (leukocyte) count (WBC)
- red blood cell (erythrocyte) count (RBC)
- hemoglobin concentration (HGB)
- hematocrit (HCT)
- mean Corpuscular (erythrocyte) Volume (MCV)
- mean Corpuscular (erythrocyte) Hemoglobin (MCH)
- mean Corpuscular (erythrocyte) Hemoglobin Concentration (MCHC)
- platelet (thrombocyte) count (PLT)
- reticulocytes (RET)
- differential white blood cell count
- activated partial thromboplastin time (APTT)
- prothrombin time (PT)
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: approx. 16 hours after last treatment (food deprived)
- Animals fasted: Yes (approx. 16 hours)
- How many animals: 5 males and 5 females per group (randomly selected)
- Parameters examined:
- alanine aminotransferase activity (ALT)
- aspartate aminotransferase activity (AST)
- total bilirubin concentration (TBIL)
- creatinine concentration (CREA)
- urea concentration (UREA)
- glucose concentration (GLUC)
- cholesterol concentration (CHOL)
- bile acids (BAC)
- sodium concentration (Na+)
- potassium concentration (K+)
- albumin concentration (ALB)
- total protein concentration (TPROT)
- T4 (in parental males at termination day 55)

URINALYSIS: No

NEUROBEHAVIOURAL EXAMINATION: Yes
Functional observation battery was performed on 5 animals per sex and group during the last exposure week but before blood sampling. Investigations included sensory reactivity to different type of stimuli (e.g. auditory, visual and proprioceptive), assessment of grip strength and motor activity. General physical conditions and behaviour of animals were tested (modified Irwin test).

IMMUNOLOGY: No

OTHER: Furthermore endpoints for toxicity to reproduction were evaluated (see Section 7.8.1)
Sacrifice and pathology:
GROSS PATHOLOGY: Yes
After examination of the external appearance, the cranial, thoracic and abdominal cavities were opened and the appearance of the tissues and organs was observed, and any abnormality was recorded including details of the location, color, shape and size. Special attention was paid to the organs of the reproductive system. The number of implantation sites was recorded (see reproductive toxicity study). The ovaries, uterus with cervix, vagina, testes, epididymides (total and cauda), prostate, and seminal vesicles with coagulating glands, adrenal glands and pituitary and all organs showing macroscopic lesions of all adult animals were preserved. Testes and epididymides were preserved in modified Davidson solution, all other organs in 4 % buffered formaldehyde solution. Thyroid gland was preserved from all adult males and females for the intended subsequent histopathological examination. Thyroid and parathyroid were preserved together with larynx.

All organs showing macroscopic lesions and the following organs were preserved in 4 % buffered formaldehyde solution (except testes and epididymides, see above) for five male and five female animals randomly selected from each group:
- adrenal glands
- bone with bone marrow and joint (femur)
- brain (representative regions: cerebrum, cerebellum, pons and medully oblongata)
- eyes (lachrymal gland with Harderian glands)
- female mammary gland
- gonads (testis with epididymides, ovaries, uterus with fallopian tube and vagina)
- gross lesions
- heart
- kidneys
- large intestines (caecum, colon, rectum, incl. Peyer's patches)
- liver
- lungs (with main stem bronchi)
- lymph nodes (submandibular, mesenteric)
- muscle (quadriceps)
- esophagus
- pancreas
- pituitary
- prostate
- salivary glands (submandibular)
- sciatic nerve
- seminal vesicle with coagulating gland
- skin
- small intestines (representative regions: duodenum, ileum, jejunum)
- spinal cord (at three levels: cervical, mid-thoracic and lumbar)
- spleen
- sternum
- stomach
- thymus
- thyroid + parathyroid
- trachea
- urinary bladder

HISTOPATHOLOGY : Yes (control and high dose group)
Full histopathological examinations were performed on the following preserved organs and tissues of selected animals in the control and high dose groups (5 per sex):
- adrenal glands
- aorta
- bone marrow
- brain
- cecum
- colon
- duodenum
- eyes + optic nerves
- esophagus
- harderian glands
- heart
- ileum
- jejunum
- kidneys
- lachrymal glands
- liver
- lungs
- mesenteric lymph nodes
- muscle (quadriceps)
- pancreas
- pituitary
- prostate
- rectum
- salivary glands (subm.)
- sciatic nerve
- skin
- spinal cord
- spleen
- sternum
- stomach - forestomach
- subm. lymph nodes
- thymus
- thyroid + parathyroid
- trachea
- urinary bladder

Histopathological examinations were performed on the following preserved organs and tissues of All animals in the control and high dose groups (12 per sex):
- ovaries (Primodial, secondary and teriary follicles; Corpora lutea)
- uterus
- vagina
- testes
- epididymides
- seminal vesicle with coagulating gland
- thymus (one male in low dose group due to hemorrhage)
Other examinations:
At the time of termination, body weight, brain weight, weight of the testes, epididymides and prostate and seminal vesicles with coagulating glands as a whole of all male adult animals were determined. Absolute organ weight was recorded. Relative organ weight (to body and brain weight) were calculated and reported.

In addition, for five males and females randomly selected from each group, adrenals, brain, heart, kidneys, liver, spleen and thymus were weighed.
The thyroid weight after fixation was not determined in the absence of changes in thyroid hormones levels.
Statistics:
Depending on variance homogeneity between groups (Bartlett's test), parametric or non-parametric (Kruskal-Wallis test) ANOVA was performed, with subsequent inter-group comparisons (Duncan multiple range test or Mann-Whitney U-Test) in case of significant ANOVA results. If applicable, the Chi-square test was performed.

Results and discussion

Results of examinations

Clinical signs:
no effects observed
Description (incidence and severity):
Daily clinical observation:
No treatment-related signs of systemic toxicity were detected at any dose level at the daily clinical observations (100, 300 and 1000 mg/kg bw/day, male or female).

Detailed weekly clinical observation:
The behavior and physical condition of animals was not affected by the test item at any dose level (100, 300 or 1000 mg/kg bw/day) based on the weekly detailed clinical observations during the entire treatment period.
Mortality:
no mortality observed
Description (incidence):
There was no mortality in any group during the course of study.
Body weight and weight changes:
no effects observed
Description (incidence and severity):
No test item related effects were noted on the mean body weight and body weight gain values at 100, 300 or 1000 mg/kg bw/day. There were no significant differences between the control and test item treated groups in the body weight or body weight gain at any occasion.
Food consumption and compound intake (if feeding study):
no effects observed
Description (incidence and severity):
There were no test item related differences in the mean daily food consumption in any test item treated group when compared to the control during the study. There were no significant differences between the control and test item treated groups in the mean daily food consumption at any occasion.
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
no effects observed
Description (incidence and severity):
There were no pathological changes in the examined hematological and blood coagulation parameters in any of the groups (male and female, 100, 300 or 1000 mg/kg bw/day). The examined hematological and blood coagulation parameters were comparable in male and female animals of control and all test item treated groups and statistical significance was not observed.
Clinical biochemistry findings:
effects observed, non-treatment-related
Description (incidence and severity):
There were no test item related adverse effects on the examined clinical chemistry parameters at 100, 300 or 1000 mg/kg bw/day (male or female).
These sporadic statistical differences are considered to be of no toxicological relevance because the differences between the control and test item treated
groups were of minor degree, the values were within the historical controls and/or they were not related to doses.
Urinalysis findings:
not examined
Behaviour (functional findings):
no effects observed
Description (incidence and severity):
Functional observations did not demonstrate any test item related changes. The behavior, physical condition and reactions to different type of stimuli of animals selected for examination are considered to be normal in all groups (100, 300 and 1000 mg/kg bw/day, control).
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
effects observed, non-treatment-related
Description (incidence and severity):
There were no test item related adverse effects on the examined organ weights in male or female animals at 100, 300 or 1000 mg/kg bw/day.
Kidney weights (absolute and relative) were reduced in a single male rat in the mid dose group. This minor change was not related to doses, the values met the historical controls and no corresponding histopathological correlate was observed. Therefore, this is considered to have no toxicological relevance.
Gross pathological findings:
effects observed, non-treatment-related
Description (incidence and severity):
Macroscopic findings related to the effect of the test item were not detected in organs or tissues of male or female animals at 100, 300 and 1000 mg/kg bw/day at necropsy. Some findings were noted in single animals of both sexes across most groups including controls (i.e. thymic hemorrhage and slight hydrometra). In the absence of related histopathological alterations (inflammatory or other pathological lesion) they were judged not to be toxicologically relevant.
Neuropathological findings:
not examined
Histopathological findings: non-neoplastic:
no effects observed
Description (incidence and severity):
Histopathological examinations did not reveal any test item related alterations in the organs or tissues of male or female animals at 1000 mg/kg bw/day. No test item related alterations in organs and tissues and no morphological evidence of acute or subacute injury to the various organs were observed.
There was no morphological evidence of acute or subacute injury (degeneration, inflammation, necrosis, etc.) of the stomach, the small and large intestines, the liver, the pancreas, the cardiovascular system, the urinary system, the immune system, the hematopoietic system, the skeleton, the muscular system, the male and female reproductive system or the central or peripheral nervous system in the animals.The cytomorphology of the endocrine glands were the same in the control and the treated animals.
Histopathological findings: neoplastic:
not examined

Effect levels

Key result
Dose descriptor:
NOAEL
Effect level:
1 000 mg/kg bw/day (actual dose received)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: No test substance related adverse effects were observed up to the highest dose tested.

Target system / organ toxicity

Key result
Critical effects observed:
no

Applicant's summary and conclusion

Conclusions:
Under the conditions of the present study, the test item did not cause signs of systemic toxicity in parental male and female Hsd.Han: Wistar rats at 100, 300 or 1000 mg/kg bw/day doses administered by oral gavage. Based on these observations the NOAEL for systemic toxicity of male/female rats was determined to be 1000 mg/kg bw/day.

Executive summary:

A study according OECD TG 422 was performed with the structurally similar substance CAS 1266615-59-1 to investigate possible effects of the test item on reproduction and development when repeatedly administered orally to rats compared to control animals. Four groups of Wistar rats consisting of 12 animals per group and sex were administered by gavage once daily doses of 0 (vehicle only), 100, 300 and 1000 mg/kg bw/day. The suitability of distilled water as vehicle for the test item was analytically verified up front as the test item was stable in distilled water at room temperature for at least four days. The concentration of the substance in the dosing formulations administered to the animals was confirmed twice during the study. All animals of the parent (P) generation were dosed prior to mating (14 days) and throughout mating. In addition, males received the test item or vehicle after mating up to the day before necropsy (altogether 56 or 57 days). Females were additionally exposed through the gestation period and up to lactation days 12-20, i.e. up to the day before necropsy (altogether for 56 to 66 days). Observations included mortality, clinical signs, body weight, food consumption, mating, pregnancy and delivery process, as well as development of offspring. Estrous cycle was monitored by examining vaginal smears before the treatment for two weeks and for two weeks from the beginning of the treatment period (two weeks pre-mating period) and during the mating period until evidence of mating. The dams were allowed to litter and rear their offspring up to day 13 post-partum. Blood samples were collected for determination of serum levels of thyroid hormones (T4) from all dams at termination on post-partum day 13 and from all parent male animals at termination. All parental animals were subjected to gross pathology one day after the last treatment. The body weight, brain weight, weight of the testes, epididymides and prostate and seminal vesicles with coagulating glands as a whole of all adult male animals were determined. Histopathology examination was performed on ovaries, uterus, vagina, testes, epididymides, prostate and seminal vesicles with coagulating gland in the control and high dose groups (male or female). Five dams and the male mating partners were randomly selected from each group to examine further signs of toxicity such as functional observations, hematology, blood coagulation, clinical chemistry, gross necropsy, and organ weighing as well as full histopathology in the control and high dose groups.

There was no mortality in any group during the course of study. Clinical signs of systemic toxicity related to the test item were not detected at any dose level, neither at the daily nor at the detailed weekly clinical observations. At the same intervals, the behavior and physical condition of the animals was not impaired at each dose level (100, 300 or 1000 mg/kg bw/day) during the entire treatment period. Test item related changes of the body weight or body weight gain were not detected. The body weight development was not disturbed and comparable in the control and test item treated groups. The mean daily food consumption was not affected by the test item in male or female animals at all test item groups during the entire study (pre-mating, post-mating, gestation and lactation periods). Clinical pathology examinations (hematology, blood coagulation, clinical chemistry and thyroid hormone levels) did not reveal toxicological relevant alterations related to the test item. Specific macroscopic alterations related to the test item were not found at necropsy. There were no test item related changes in the weights (absolute and relative to body or brain weights) of selected organs in the animals at any dose level.

Histopathological examinations of the selected organs (ovaries, uterus, vagina, testes, epididymides, prostate and seminal vesicles with coagulating gland) did not reveal any test item related changes at the highest dose of 1000 mg/kg bw/day. During full histopathology, there were no changes related to the test item in organs or tissues of selected animals (male or female) at 1000 mg/kg bw/day.

Under the conditions of the present study, the substance did not cause signs of systemic toxicity in parental male and female Hsd.Han: Wistar rats at 100, 300 or 1000 mg/kg bw/day doses administered by oral gavage. Based on these observations the NOAEL were determined as follows:

NOAEL for systemic toxicity of male/female rats: 1000 mg/kg bw/day